Shaun Stauffer

14PUBLICATIONS
69CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsProteins and peptidesPredictive and prognostic markersPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 22, 2026
Structure-guided optimization of SLC1A1/EAAT3-selective inhibitors targeting renal cancer metabolism.

|Feb 16, 2026
Fragment-Based Development of NSP14 Exonuclease Inhibitors Confounded by Batch-to-Batch Variability.

Jesse A Coker, Rong Sun, Paul M Polzer

|Oct 09, 2025
The Same and Not the Same: Discovery of S-892216, A Second-Generation Nonpeptidic Covalent 3CL Protease Inhibitor for Oral COVID-19 Therapeutics.

Shaun R Stauffer

|Sep 05, 2025
MCL1 may not mediate chemoresistance.

Kylin A Emhoff, Kunho Chung, Dongmei Zhang

|Jun 04, 2025
Characterization of Hepatotropic Small Molecule Inhibitors of Hypoxia Inducible Factor Prolyl Hydroxylase in the Prevention of Oxygen-Induced Retinopathy.

Christie Campla, George Hoppe, Minzhong Yu

|Dec 20, 2024
WD repeat domain 5 (WDR5) inhibitors: a patent review (2016-present).

Jesse A Coker, Shaun R Stauffer

Pageof 3

Frequent Collaborators

6 joint publications

Jesse A Coker

3 joint publications

Christopher M Goins

2 joint publications

Jonathan D Macdonald

1 joint publications

Chitra Rawat